Relative V Beta Transcript Levels in Thymus and Peripheral Lymphoid Tissues from Various Mouse Strains. Inverse Correlation of I-E and Mls Expression with Relative Abundance of Several V Beta Transcripts in Peripheral Lymphoid Tissues
Overview
General Medicine
Authors
Affiliations
We have measured the relative levels of transcripts for 15 of the 22 known V beta gene segments. The level of transcripts for the highest and lowest expressed V beta gene segment differed by greater than 20-fold in the thymus and an even larger difference was observed in the periphery. The levels of expressions were unrelated to the order of the V beta genes on the chromosome. For most of the V beta gene segments, the relative transcript levels were the same in the thymus and periphery, suggesting that thymic selection in general does not act solely upon the V beta gene segment. One V beta gene segment in the BALB and B10 mice strains was an exception to this rule. V beta 5.2 expression in the periphery of BALB and B10 mice inversely correlated with the expression of the MHC class II molecule I-E. Five V beta gene segments had reduced transcript levels in the periphery of Mls-1a mice compared with their thymic levels or to the levels found in Mls-1b mice. The peripheral level of V beta 3 transcripts vary with MHC and Mls-2 haplotypes. The observation that certain V beta transcript levels are reduced in the periphery when compared with the thymus favors the hypothesis that self tolerance at the T cell level results in the elimination of self-reactive T cells, rather than paralysis by a block at some post-transcriptional step. Finally, the wide variability of V beta gene segment expression in the thymus suggests mechanisms exist to import an early bias to the repertoire. Whether this bias results from differential V beta segment rearrangement rates, differential V beta expression rates, or events occurring after TCR-alpha/beta expression on immature/nonmature thymocyte cell surfaces is yet to be determined.
Mandl J, Monteiro J, Vrisekoop N, Germain R Immunity. 2013; 38(2):263-274.
PMID: 23290521 PMC: 3785078. DOI: 10.1016/j.immuni.2012.09.011.
Young H Methods Mol Biol. 2009; 511:85-105.
PMID: 19347294 PMC: 6629022. DOI: 10.1007/978-1-59745-447-6_4.
Ryu C, Haines B, Lee H, Kang Y, Draganov D, Lee M Mol Cell Biol. 2004; 24(16):7015-23.
PMID: 15282302 PMC: 479718. DOI: 10.1128/MCB.24.16.7015-7023.2004.
Deepe Jr G, Gibbons R, Ward S Infect Immun. 2002; 70(3):1648-52.
PMID: 11854260 PMC: 127812. DOI: 10.1128/IAI.70.3.1648-1652.2002.
Huang Y, Ildstad S, Neipp M, Shirwan H Immunology. 2000; 100(3):317-25.
PMID: 10929053 PMC: 2327025. DOI: 10.1046/j.1365-2567.2000.00049.x.